NSC |
Compound |
Enrichment |
Correlation |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
0.0110679092462694 |
0.38541496 |
NSC 753222 |
3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline |
0.0110679092462694 |
0.16608756 |
NSC 75382 |
Thiophene, tetrahydro-3,4-dibromo-, 1,1-dioxide |
0.0110679092462694 |
0.4094215 |
NSC 754385 |
1-[bis(4,4'-aminophenyl)methylidenyl]-[3]ferrocenophane |
0.0110679092462694 |
0.20437407 |
NSC 761676 |
Null |
0.0110679092462694 |
0.33571603 |
NSC 80103 |
2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) |
0.0110679092462694 |
0.36114137 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0110679092462696 |
0.13417124 |
NSC 160121 |
1H,5H-Benzo[ij]quinolizine, 2,3,6,7-tetrahydro-9-(octylamino)-, dihydrochloride |
0.0110679092462696 |
0.42490964 |
NSC 265211 |
NSC 265211 |
0.0110679092462696 |
0.056044405 |
NSC 287459 |
Cytarabine AY |
0.0110679092462696 |
0.35515335 |